The burden of end-stage renal disease in Khartoum, Sudan: cost of illness study

References

• Benjamin O, Lappin SL. End-Stage renal disease. 2021 Sep 16. In: StatPearls [internet]. Treasure Island (FL): statPearls Publishing; 2022 Jan. PMID: 29763036.
   Google Scholar
• Delanaye P, Jager KJ, Bökenkamp A, et al. CKD: a call for an age-adapted definition. J Am Soc Nephrol. 2019;30(10):1785–1805. doi:10.1681/ASN.2019030238.
   PubMed Web of Science ®Google Scholar
• Ren F, Li M, Xu H, et al. Urine albumin-to-creatinine ratio within the normal range and risk of hypertension in the general population: a meta-analysis. J Clin Hypertens (Greenwich). 2021 Jul;23(7):1284–1290. Epub 2021 Jun 5. PMID: 34089300; PMCID: PMC8678728. doi:10.1111/jch.14263.
   PubMed Web of Science ®Google Scholar
• Arogundade FA, Omotoso BA, Adelakun A, et al. The burden of end-stage renal disease in Sub-saharan africa. Clin Nephrol. 2020;93(1):3–7. doi:10.5414/CNP92S101.
   PubMedGoogle Scholar
• Asgeirsdottir TL, Asmundsdottir G, Heimisdottir M[, et al. Cost-effectiveness analysis of treatment for end-stage renal disease. Laeknabladid. 2009 Nov;95(11):747–753.
   PubMed Web of Science ®Google Scholar
• Hessel F. Burden of disease. In: Kirch W, editor. Encyclopedia of public health. Dordrecht: Springer; 2008. doi:10.1007/978-1-4020-5614-7_297.
   Google Scholar
• Kassa DA, Mekonnen S, Kebede A, et al. Cost of hemodialysis treatment and associated factors among end-stage renal disease patients at the tertiary hospitals of Addis Ababa city and Amhara region, Ethiopia. Clinicoecon Outcomes Res. 2020;12:399–409. doi:10.2147/CEOR.S256947.
   PubMed Web of Science ®Google Scholar
• Wang V, Vilme H, Maciejewski ML, et al. The economic burden of chronic kidney disease and end-stage renal disease. Semin Nephrol. 2016;36(4):319–330. JulPubMed PMID: 27475662. doi:10.1016/j.semnephrol.2016.05.008.
   PubMed Web of Science ®Google Scholar
• Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327–337. doi:10.3350/cmh.2014.20.4.327.
   PubMedGoogle Scholar
• Glied S, Smith PC. The oxford handbook of health economics. Oxford University Press; 2011. Available from: https://global.oup.com/academic/product/the-oxford-handbook-of-healtheconomics-9780199675401?cc=us&lang=en&
   Google Scholar
• Cochran WG. 1977). Sampling techniques. (3rd ed.). New York: John Wiley & Sons.
   Google Scholar
• Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet. 2020 Feb 29;395(10225):662–664. doi:10.1016/S0140-6736(19)32977-0.Epub 2020 Feb 13. PMID: 32061314.
   PubMed Web of Science ®Google Scholar
• Tool to estimate patient costs_Questionnaire_final.doc. https://view.officeapps.live.com/op/view.asp?src=https://stoptb.org/wg/dots expansion/tbandpoverty/assets/documents/5 tool to estimate patient costs questionnaire final. doc&dorigin=browselink.
   Google Scholar
• Von Elm E, Altman DG, Egger M, et al. STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007 Oc;t 20;370(9596):1453–1457. PMID: 18064739 doi:10.1016/S0140-6736(07)61602-X.
   PubMed Web of Science ®Google Scholar
• Yousif AO, Idris AKM, Awad MM, et al. Out‐of‐pocket payments by end‐stage kidney disease patients on regular hemodialysis: cost of illness analysis, experience from Sudan. Hemodial Int. 2021;25(1):123–130. doi:10.1111/hdi.12895.
   PubMed Web of Science ®Google Scholar
• Banaga AS, Mohammed EB, Siddig RM, et al. Causes of end stage renal failure among haemodialysis patients in Khartoum state/Sudan. BMC Res Notes. 2015;8(1):502. doi:10.1186/s13104-015-1509-x.
   PubMedGoogle Scholar
• Zhang H, Zhang C, Zhu S, et al. Direct medical costs of end stage kidney disease and renal replacement therapy: a cohort study in guangzhou city, Southern China. BMC Health Serv Res. 2020;20(1):122. doi:10.1186/s12913-020-4960-x.
   PubMed Web of Science ®Google Scholar
• Wong CK, Chen J, Fung SK, et al. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis. Nephrol Dial Transplant. 2019;34(9):1565–1576. doi:10.1093/ndt/gfy395.
   PubMed Web of Science ®Google Scholar
• Kennedy C, Ryan S, Kane T, et al. The impact of change of renal replacement therapy modality on sleep quality in patients with end stage renal disease: a systematic review and meta-analysis. J Nephrol. 2018;31(1):61–70. doi:10.1007/s40620-017-0409-7.
   PubMed Web of Science ®Google Scholar
• Suja A, Anju R, Anju V, et al. Economic evaluation of end stage renal disease patients undergoing hemodialysis. J Pharm Bioallied Sci. 2012;4(2):107–111. doi:10.4103/0975-7406.94810.
   PubMedGoogle Scholar
• Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–957. doi:10.1038/ki.2015.230.
   PubMed Web of Science ®Google Scholar
• Peixoto AJ, Orias M, Desir GV. Does kidney disease cause hypertension? Curr Hypertens Rep. 2013 Apr;15(2):89–94. PMID: 23344662. doi:10.1007/s11906-013-0327-6.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Klag MJ. Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence. Hypertension. 1989 May;13(5 Suppl):I19–27. PMID: 2490824. doi:10.1161/01.hyp.13.5_suppl.i19.
   PubMedGoogle Scholar
• Barri YM. Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep. 2008 Feb;10(1):39–45. PMID: 18367025. doi:10.1007/s11906-008-0009-y.
   PubMed Web of Science ®Google Scholar
• Arogundade F, Sanusi A, Hassan M, et al. The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria: is there a change in trend? Afr Health Sci. 2011;11(4):594–601.
   PubMed Web of Science ®Google Scholar
• Cao Y, Li W, Yang G, et al. Diabetes and hypertension have become leading causes of CKD in chinese elderly patients: a comparison between 1990- 1991 and 2009-2010. Int Urol Nephrol. 2012;44(4):1269–1276. AugPubMed PMID: 22648290 doi:10.1007/s11255-012-0194-0.
   PubMed Web of Science ®Google Scholar
• Martínez‐Maldonado M. Role of hypertension in the progression of chronic renal disease. Nephrol Dial Transplant. May 2001;16Issue(suppl_1):63–66. volume Pages doi:10.1093/ndt/16.suppl_1.63.
   PubMedGoogle Scholar
• Al Saran K, Sabry A. The cost of hemodialysis in a large hemodialysis center. Saudi J Kidney Dis Transpl. 2012;23(1):78.
   PubMedGoogle Scholar
• Salim AMA, Hamed FHM. Exploring health insurance services in Sudan from the perspectives of insurers. SAGE Open Med. 2018;6:2050312117752298. doi:10.1177/2050312117752298.
   Web of Science ®Google Scholar
• Villa G, Rodríguez-Carmona A, Fernández-Ortiz L, et al. Cost analysis of the spanish renal replacement therapy programme. Nephrol Dial Transplant. 2011;26(11):3709–3714. doi:10.1093/ndt/gfr088.
   PubMed Web of Science ®Google Scholar
• Hirth RA, Greer SL, Albert JM, et al. Out-of-pocket spending and medication adherence among dialysis patients in twelve countries. Health Aff (Millwood). 2008;27(1):89–102. doi:10.1377/hlthaff.27.1.89.
   PubMed Web of Science ®Google Scholar
• Dodd R, Palagyi A, Guild L, et al. The impact of out-of-pocket costs on treatment commencement and adherence in chronic kidney disease: a systematic review. Health Policy Plan. 2018;33(9):1047–1054. doi:10.1093/heapol/czy081.
   PubMed Web of Science ®Google Scholar
• Nguyen KT, Khuat OT, Ma S, et al. Effect of health expenses on household capabilities and resource allocation in a rural commune in vietnam. PLoS One. 2012;7(10):e47423. doi:10.1371/journal.pone.0047423.
   PubMed Web of Science ®Google Scholar